We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.29%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+106.29%
3 Year Est. Return
+266.67%
5 Year Est. Return
+310.43%
10 Year Est. Return
+1,579.99%
AUM
$4.87B
AUM Growth
+$553M
Cap. Flow
+$147M
Cap. Flow %
3.01%
Top 10 Hldgs %
9.64%
Holding
2,743
New
781
Increased
556
Reduced
401
Closed
657

Sector Composition

Rank Sector Weight
1 Financials 14.84%
2 Healthcare 10.37%
3 Technology 8.45%
4 Consumer Discretionary 7.09%
5 Industrials 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPPI
2001
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$22.8K ﹤0.01%
30,401
AIMDW icon
2002
Ainos Warrants
AIMDW
$21.8K ﹤0.01%
25,000
ONFO icon
2003
Onfolio Holdings
ONFO
$422K
$21.2K ﹤0.01%
13,256
-11,744
-47% -$20.8K
BMAQR
2004
DELISTED
Blockchain Moon Acquisition Corp. Rights
BMAQR
$20.5K ﹤0.01%
391,125
DISTR
2005
DELISTED
Distoken Acquisition Corporation Right
DISTR
$19.7K ﹤0.01%
+151,200
New +$20K
SYBX
2006
DELISTED
Synlogic
SYBX
$19.5K ﹤0.01%
2,058
FSP
2007
Franklin Street Properties
FSP
$47.1M
$19K ﹤0.01%
+12,096
New +$30.4K
NEXRW
2008
Nexera Technologies Ltd Warrant
NEXRW
$41.4K
$18.7K ﹤0.01%
24,038
QBTS.WS
2009
DELISTED
D-Wave Quantum Inc Warrants
QBTS.WS
$17.8K ﹤0.01%
26,779
HHGCR
2010
DELISTED
HHG Capital Corporation Rights
HHGCR
$17.4K ﹤0.01%
125,000
WULF icon
2011
TeraWulf
WULF
$8.79B
$15.9K ﹤0.01%
+16,906
New +$12.6K
DRMAW icon
2012
Dermata Therapeutics Warrant
DRMAW
$14.1K
$15.5K ﹤0.01%
12,000
BLCM
2013
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$14.9K ﹤0.01%
45,057
WKHS icon
2014
Workhorse Group
WKHS
$35.2M
$14.3K ﹤0.01%
+4
New +$22.1K
MSPRZ
2015
DELISTED
MSP Recovery Inc Warrant
MSPRZ
$13.3K ﹤0.01%
+15,672
New +$19.1K
NXLIW
2016
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$10.8K ﹤0.01%
13,500
BRLIR
2017
DELISTED
Brilliant Acquisition Corporation Rights
BRLIR
$10.7K ﹤0.01%
74,155
CPTNW
2018
DELISTED
Cepton, Inc. Warrant
CPTNW
$10.5K ﹤0.01%
22,591
LGHLW
2019
DELISTED
Lion Group Holding Ltd. Warrant
LGHLW
$10.3K ﹤0.01%
32,895
FNCH
2020
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$9.39K ﹤0.01%
796
AREBW
2021
DELISTED
American Rebel Holdings Warrants
AREBW
$8.56K ﹤0.01%
602
STSA
2022
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$8.36K ﹤0.01%
11,968
HMACR
2023
DELISTED
Hainan Manaslu Acquisition Corp. Right
HMACR
$7.03K ﹤0.01%
37,000
NCMI icon
2024
National CineMedia
NCMI
$378M
$6.43K ﹤0.01%
+4,870
New +$11.4K
VBIO
2025
Valion Bio
VBIO
$1.14M
$4.52K ﹤0.01%
+18
New +$12.6K

Similar funds

Boothbay Fund Management's Q1 2023 Portfolio in Review

As of Q1 2023, Boothbay Fund Management held 2,743 positions worth $4.87B, up 13% from $4.32B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Boothbay Fund Management deployed $147M of net new capital in Q1 2023, opening 781 new positions and adding to 556 existing holdings. Its largest new stake was Abbott: 158,585 shares worth $16.1M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $33.9M trimmed.

  • Boothbay Fund Management's largest Q1 2023 buy was Abbott: 158,585 shares worth $16.1M.
  • Boothbay Fund Management added most to Churchill Capital Corp VII Class A Common Stock in Q1 2023, an estimated $25.2M increase.
  • Boothbay Fund Management's biggest Q1 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $33.9M.
  • Boothbay Fund Management fully exited RMG Acquisition Corp. III Class A Ordinary Shares in Q1 2023, selling an estimated $20.5M.
  • Boothbay Fund Management's ten largest holdings make up 9.6% of its $4.87B portfolio in Q1 2023.
  • Boothbay Fund Management opened 781 new positions and closed 657 in Q1 2023.
  • Boothbay Fund Management's portfolio value rose 13% quarter-over-quarter to $4.87B.

Based on Boothbay Fund Management's 13F filing for Q1 2023, filed 15 May 2023.